A Leader in Scientific Breakthroughs
BrightFocus Foundation is a premier private funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. We are currently managing a nearly $65 million global portfolio of more than 260 scientific projects.
Recently Funded
Learn more about grants awarded in the most current fiscal year. More than $25 million in funding for 106 new awards in FY2021.
Apply for a Grant
To start a new application and upload attachments, you must use our ProposalCentral application portal to apply online. Click one of the links to proceed to the RFPs.
Featured
BrightFocus Foundation will hold the third Glaucoma Fast Track to accelerate the fight for a cure by investing in promising young scientists in the field of vision research.
Extracellular vesicles isolated from the blood of people with Down syndrome-related Alzheimer’s disease have been shown to seed toxic tau species in the brains of normal mice, shedding light on the uptake and transmission of toxic tau.
BrightFocus-funded researchers were among the first to “map” the normal 3D structure of a protein called myocilin, which is abundant in the drainage pathway of the eye. Now, with a second grant, they’ve designed antibodies to help diagnose and treat myocilin misfolding as it contributes to glaucoma.